SPOTLIGHT -
EP. 1: Heritable Prostate Cancer: Germline vs Somatic Mutations
EP. 2: Genetic Testing in Prostate Cancer
EP. 3: Molecular Testing in Prostate Cancer
EP. 4: Active Surveillance in Prostate Cancer
EP. 5: Combination Therapies in Localized Prostate Cancer
EP. 6: Abiraterone and Chemotherapy in CRPC
EP. 7: Radiation Therapy and ADT in CRPC
EP. 8: Sequencing and Layering of Drugs in CRPC
EP. 9: AR-V7 Testing in mCRPC
EP. 10: Future of PARP Inhibitors in mCRPC
EP. 11: Radium-223 in mCRPC
EP. 12: Radium-223 in Combination Therapy for mCRPC
EP. 13: Future Directions in Treating Advanced Prostate Cancer
Long-Term HRQOL Remains Unimpaired With HIPEC Plus Cytoreductive Surgery in Newly Diagnosed Ovarian Cancer
Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors
Navigating Systemic Therapy for RCC: Balancing Risk Status and Response
ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC
